0001564590-22-014494.txt : 20220414 0001564590-22-014494.hdr.sgml : 20220414 20220414170053 ACCESSION NUMBER: 0001564590-22-014494 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220405 ITEM INFORMATION: Cost Associated with Exit or Disposal Activities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events FILED AS OF DATE: 20220414 DATE AS OF CHANGE: 20220414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMARA Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 22828052 BUSINESS ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-206-2020 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 8-K 1 imra-8k_20220405.htm 8-K imra-8k_20220405.htm
false 0001672619 0001672619 2022-04-05 2022-04-05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 5, 2022

 

IMARA INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

 

001-39247

 

81-1523849

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

 

 

 

116 Huntington Avenue, 6th Floor

Boston, MA

 

 

 

02116

(Address of Principal Executive Offices)

 

 

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (617) 206-2020

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

IMRA

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 2.05

Costs Associated with Exit or Disposal Activities.

On April 12, 2022, the Board of Directors (“Board”) of IMARA Inc. (the “Company”) approved a reduction of the Company’s workforce (the “Workforce Reduction”) by approximately 83% across all areas of the Company, to a total of six remaining full-time employees.  The Workforce Reduction follows the Company’s decision, further described below, to discontinue development of tovinontrine (IMR-687) in sickle cell disease, beta-thalassemia and heart failure with preserved ejection fraction, as well to discontinue its development plans with respect to IMR-261. The Workforce Reduction is expected to be substantially completed by the end of the second quarter of 2022.  The Workforce Reduction is designed to substantially reduce the Company’s operating expenses while the Company undertakes a comprehensive assessment of its strategic options to maximize shareholder value.

Affected employees will be offered separation benefits, including severance payments, healthcare coverage and related benefits. The Company expects to record a one-time restructuring charge of approximately $2.0 to $2.2 million primarily related to severance, healthcare coverage and other employee termination-related costs in the second quarter of 2022. The estimate of costs that the Company expects to incur, and the timing thereof, are subject to a number of assumptions and actual results may differ. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the Workforce Reduction.

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

In connection with the Workforce Reduction, Kenneth Attie, M.D., the Company’s Chief Medical Officer will separate from the Company effective April 20, 2022.  

Item 8.01

Other Events.

On April 5, 2022, the Company issued a press release announcing results from interim analyses of its Ardent Phase 2b clinical trial of tovinontrine in patients with sickle cell disease and Forte Phase 2b clinical trial of tovinontrine in patients with beta-thalassemia, and its decision to discontinue the Ardent and Forte trials as well as the further development of tovinontrine in sickle cell disease and beta-thalassemia.   On April 10, 2022, the Board of the Company determined to also discontinue development of tovinontrine in heart failure with preserved ejection fraction, as well as the Company’s development plans with respect to IMR-261.  The Company has initiated a process to comprehensively evaluate its strategic options to maximize shareholder value.

Cautionary Note Regarding Forward-Looking Statements

Statements in this Current Report on Form 8-K about future expectations and plans, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the Company’s (i) workforce reduction and future charges expected to be incurred in connection therewith, (ii) plans to discontinue development of tovinontrine and IMR-261 and (iii) plans to initiate a process to evaluate its strategic options. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the impact of extraordinary external events, such as the risks and uncertainties resulting from the impact of the COVID-19 pandemic; the risk that the Company may not be able to successfully implement its strategic plans; and other factors discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K, which is on file with the Securities and Exchange Commission and in other filings that the Company makes with the Securities and Exchange Commission in the future. Any forward-looking statements contained in this Current Report on Form 8-K speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

IMARA INC.

 

 

 

 

Date: April 13, 2022

 

By:

/s/ Rahul D. Ballal, Ph.D.

 

 

 

Name: Rahul D. Ballal

 

 

 

Title: President and Chief Executive Officer

 

 

 EX-101.SCH 2 imra-20220405.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 imra-20220405_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 4 imra-20220405_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
Apr. 05, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 05, 2022
Entity Registrant Name IMARA INC.
Entity Central Index Key 0001672619
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity File Number 001-39247
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 81-1523849
Entity Address, Address Line One 116 Huntington Avenue
Entity Address, Address Line Two 6th Floor
Entity Address, City or Town Boston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02116
City Area Code 617
Local Phone Number 206-2020
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol IMRA
Security Exchange Name NASDAQ
XML 6 imra-8k_20220405_htm.xml IDEA: XBRL DOCUMENT 0001672619 2022-04-05 2022-04-05 false 0001672619 8-K 2022-04-05 IMARA INC. DE 001-39247 81-1523849 116 Huntington Avenue 6th Floor Boston MA 02116 617 206-2020 false false false false Common Stock, par value $0.001 per share IMRA NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports imra-8k_20220405.htm imra-20220405.xsd imra-20220405_lab.xml imra-20220405_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "imra-8k_20220405.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "imra-8k_20220405.htm" ] }, "labelLink": { "local": [ "imra-20220405_lab.xml" ] }, "presentationLink": { "local": [ "imra-20220405_pre.xml" ] }, "schema": { "local": [ "imra-20220405.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "imra", "nsuri": "http://imaratx.com/20220405", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "imra-8k_20220405.htm", "contextRef": "C_0001672619_20220405_20220405", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "imra-8k_20220405.htm", "contextRef": "C_0001672619_20220405_20220405", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imaratx.com/20220405/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0001564590-22-014494-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-014494-xbrl.zip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